Clinical Trial Update: Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cyclophosphamide and fludarabine followed by cellular adoptive immunotherapy and vaccine therapy in metastatic melanoma; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cellular Adoptive Immunotherapy
• Cytoxan (cyclophosphamide)
• Fludara (fludarabine)
• Vaccine therapy

Snippet

Sponsor: Prof. Serge Leyvraz | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED